List of Session for which you can submit abstracts

Abstract Submission

Core Symposia

Title Chairperson
1 Single cell biology of human cancer Hiroyuki Aburatani
Shumpei Ishikawa
The University of Tokyo
The University of Tokyo
2 Precision disease modeling: organoid-driven cancer research Toshiro Sato
Hiroshi Seno
Keio University
Kyoto University

International Sessions

  Title Chaiperson
1 Extracellular vesicle-mediated cross-talk in cancer Takahiro Ochiya
Tang-Long Shen
Tokyo Medical University
National Taiwan University
2 Cell death, tumor suppressors and beyond Chiaki Takahashi
Sharad Kumar
Kanazawa University
University of South Australia
3 Epitranscriptome and tumor Heterogeneity Hideshi Ishii
Hao-Jian Zhang
Osaka University
Wuhan University
4 Targeting super-enhancers in intractable cancer Miwa Tanaka
H. Phillip Koeffler
The Cancer Inst., JFCR
National University of Singapore
5 Advances in cellular immunotherapy Naoki Hosen
Chenqi Xu
Osaka University
Chinese Academy of Sciences
6 Epigenomic rewiring for oncogenic signal activation Atsushi Kaneda
Patrick Tan
Chiba University
Duke-NUS Medical School
7 Potentials of simulation modelling research in cancer control Kota Katanoda
Eleonora Feletto
National Cancer Center
Cancer Council New South Wales
8 Theoretic strategy for immune checkpoint inhibitor-based combination therapy Kenji Chamoto
Mien-Chie Hung
Kyoto University
China Medical University
9 Super-acceleration of early drug development Ken-ichiro Kamei

Lijian Hui
Kyoto University Institute for Advanced Study
Chinese Academy of Sciences
10 Single-cell analysis in cancer research Shinichi Yachida
Woong-Yang Park
Osaka University
Sungkyunkwan University
11 Frontline of genomic research in cancer Keisuke Kataoka
Hongbin Shen
Keio University
Nanjing Medical University

Symposia

  Title Chairperson
1 Forefront research on chromatin dynamics and its application to cancer medicine Hiroyuki Seimiya
Makoto Nakanishi
Japanese Foundation For Cancer Research
The University of Tokyo
2 Metastasis: development of novel strategies through multifaceted understanding Kyoko Hida
Daizo Koinuma
Hokkaido University
The University of Tokyo
3 Development of cancer immunotherapy for precision medicine Hiroyoshi Nishikawa
Kazuma Kiyotani
National Cancer Center
Japanese Foundation For Cancer Research
4 Evolving molecular targeted therapy Seiji Yano
Ryohei Katayama
Kanazawa University
Japanese Foundation for Cancer Research
5 Aging with and without cancer Eiji Hara
Hozumi Motohashi
Osaka University
Tohoku University
6 Cancer metabolism: beyond the Warburg Atsushi Hirao
Tomoyoshi Soga
Kanazawa University
Keio University
7 Futuristic methods for precision cancer medicine Hiroshi Nishihara
Issei Imoto
Keio University
Aichi Cancer Center Hospital
8 Understanding and targeting genetically-complex human malignancies Masaki Mori
Fumihiko Ishikawa
Kyushu University
RIKEN
9 Phenotypic heterogeneity and plasticity in cancer regulated by epigenetic mechanisms Issay Kitabayashi

Mitsuyoshi Nakao
National Cancer Center Research Institute
Kumamoto University
10 Evolution of pathology: from morphological diagnosis towards a universal research platform Yae Kanai
Kengo Takeuchi
Keio University
Japanese Foundation for Cancer Research
11 Genomic analysis toward future clinical application Johji Inazawa

Katsutoshi Oda
Tokyo Medical and Dental University
The University of Tokyo
12 Microbiota and cancer Kenya Honda
Naoko Ohtani
Keio University
Osaka City University
13 Cutting-edge animal models for cancer research Yasuhiro Yamada
Masato Kanemaki
The University of Tokyo
National Institute of Genetics
14 Elucidating how chromosomal instability arises to identify cancer therapy targets Kozo Tanaka
Ryu-Suke Nozawa
Tohoku University
Japanese Foundation For Cancer Research
15日本語 Issues and future directions of academia-pharma collaborations for novel drug development Naoya Fujita

Noriko Gotoh
Japanese Foundation for
Research Institute Kanazawa University
16 Big data in cancer research Seiya Imoto
Hiroaki Miyata
The University of Tokyo
Keio University
17 Novel functions and clinical application of the most famous tumor suppressor gene p53 Rieko Ohki

Tomoaki Tanaka
National Cancer Center Research Institute
Chiba University
18 Latest evidence and perspective on liquid biopsy Takayuki Yoshino

Koji Ueda
National Cancer Center Hospital East
Japanese Foundation for Cancer Research
19 New horizons in tumor microenvironment regulation targeting inflammation and angiogenesis Tetsuro Watabe

Masanobu Oshima
Tokyo Medical and Dental University
Kanazawa University
20 Drug discovery and diagnosis enhanced with AI  Satoru Miyano

Masahiro Jinzaki
Tokyo Medical and Dental University
Keio University
21 Next-generation imaging tools pioneered by light Shinae Kizaka-Kondoh
Mako Kamiya
Tokyo Institute of Technology
The University of Tokyo
22 Relationship between clonal hematopoiesis and hematological malignancies/cardiovascular diseases/solid tumors Toshio Kitamura
Atsushi Iwama
The University of Tokyo
The University of Tokyo